300 related articles for article (PubMed ID: 21989597)
1. Heterozygous ABCC8 mutations are a cause of MODY.
Bowman P; Flanagan SE; Edghill EL; Damhuis A; Shepherd MH; Paisey R; Hattersley AT; Ellard S
Diabetologia; 2012 Jan; 55(1):123-7. PubMed ID: 21989597
[TBL] [Abstract][Full Text] [Related]
2. Dominantly acting ABCC8 mutations in patients with medically unresponsive hyperinsulinaemic hypoglycaemia.
Flanagan SE; Kapoor RR; Banerjee I; Hall C; Smith VV; Hussain K; Ellard S
Clin Genet; 2011 Jun; 79(6):582-7. PubMed ID: 20573158
[TBL] [Abstract][Full Text] [Related]
3. Genetics of type 2 diabetes mellitus and other specific types of diabetes; its role in treatment modalities.
Kota SK; Meher LK; Jammula S; Kota SK; Modi KD
Diabetes Metab Syndr; 2012; 6(1):54-8. PubMed ID: 23014256
[TBL] [Abstract][Full Text] [Related]
4. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism.
Kapoor RR; Flanagan SE; Arya VB; Shield JP; Ellard S; Hussain K
Eur J Endocrinol; 2013 Apr; 168(4):557-64. PubMed ID: 23345197
[TBL] [Abstract][Full Text] [Related]
5. Co-inheritance of two ABCC8 mutations causing an unresponsive congenital hyperinsulinism: clinical and functional characterization of two novel ABCC8 mutations.
Faletra F; Snider K; Shyng SL; Bruno I; Athanasakis E; Gasparini P; Dionisi-Vici C; Ventura A; Zhou Q; Stanley CA; Burlina A
Gene; 2013 Mar; 516(1):122-5. PubMed ID: 23266803
[TBL] [Abstract][Full Text] [Related]
6. Molecular Genetics, Clinical Characteristics, and Treatment Outcomes of K
Ngoc CTB; Dien TM; De Franco E; Ellard S; Houghton JAL; Lan NN; Thao BP; Khanh NN; Flanagan SE; Craig ME; Dung VC
Front Endocrinol (Lausanne); 2021; 12():727083. PubMed ID: 34566892
[TBL] [Abstract][Full Text] [Related]
7. Monogenic models: what have the single gene disorders taught us?
Klupa T; Skupien J; Malecki MT
Curr Diab Rep; 2012 Dec; 12(6):659-66. PubMed ID: 22996131
[TBL] [Abstract][Full Text] [Related]
8. A mutation (R826W) in nucleotide-binding domain 1 of ABCC8 reduces ATPase activity and causes transient neonatal diabetes.
de Wet H; Proks P; Lafond M; Aittoniemi J; Sansom MS; Flanagan SE; Pearson ER; Hattersley AT; Ashcroft FM
EMBO Rep; 2008 Jul; 9(7):648-54. PubMed ID: 18497752
[TBL] [Abstract][Full Text] [Related]
9. High Incidence of Heterozygous ABCC8 and HNF1A Mutations in Czech Patients With Congenital Hyperinsulinism.
Rozenkova K; Malikova J; Nessa A; Dusatkova L; Bjørkhaug L; Obermannova B; Dusatkova P; Kytnarova J; Aukrust I; Najmi LA; Rypackova B; Sumnik Z; Lebl J; Njølstad PR; Hussain K; Pruhova S
J Clin Endocrinol Metab; 2015 Dec; 100(12):E1540-9. PubMed ID: 26431509
[TBL] [Abstract][Full Text] [Related]
10. Molecular and clinical features of K
Hashimoto Y; Dateki S; Hirose M; Satomura K; Sawada H; Mizuno H; Sugihara S; Maruyama K; Urakami T; Sugawara H; Shirai K; Yorifuji T
Pediatr Diabetes; 2017 Nov; 18(7):532-539. PubMed ID: 27681997
[TBL] [Abstract][Full Text] [Related]
11. A beneficial role of GLP-1 receptor agonist therapy in ABCC8-MODY (MODY 12).
Nakhleh A; Goldenberg-Furmanov M; Goldstein R; Shohat M; Shehadeh N
J Diabetes Complications; 2023 Sep; 37(9):108566. PubMed ID: 37536118
[TBL] [Abstract][Full Text] [Related]
12. Long-term Follow-up of Glycemic and Neurological Outcomes in an International Series of Patients With Sulfonylurea-Treated
Bowman P; Mathews F; Barbetti F; Shepherd MH; Sanchez J; Piccini B; Beltrand J; Letourneau-Freiberg LR; Polak M; Greeley SAW; Rawlins E; Babiker T; Thomas NJ; De Franco E; Ellard S; Flanagan SE; Hattersley AT;
Diabetes Care; 2021 Jan; 44(1):35-42. PubMed ID: 33184150
[TBL] [Abstract][Full Text] [Related]
13. Monogenic Forms of Diabetes Mellitus.
Gaál Z; Balogh I
Exp Suppl; 2019; 111():385-416. PubMed ID: 31588541
[TBL] [Abstract][Full Text] [Related]
14. Transient neonatal diabetes due to a disease causing novel variant in the ATP-binding cassette subfamily C member 8 (
Giannopoulou EZ; Ovcarov O; De Franco E; Kassberger F; Nusser S; Otto MC; Denzer C; Wabitsch M
J Pediatr Endocrinol Metab; 2021 Feb; 34(2):273-276. PubMed ID: 33185579
[TBL] [Abstract][Full Text] [Related]
15. Phenotype, genotype and glycaemic variability in people with activating mutations in the ABCC8 gene: response to appropriate therapy.
Reilly F; Sanchez-Lechuga B; Clinton S; Crowe G; Burke M; Ng N; Colclough K; Byrne MM
Diabet Med; 2020 May; 37(5):876-884. PubMed ID: 31562829
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of ABCC8, KCNJ11, GLUD1, HNF4A and GCK genes in 30 Chinese patients with congenital hyperinsulinism.
Sang Y; Xu Z; Liu M; Yan J; Wu Y; Zhu C; Ni G
Endocr J; 2014; 61(9):901-10. PubMed ID: 25008049
[TBL] [Abstract][Full Text] [Related]
17. KCNJ11, ABCC8 and TCF7L2 polymorphisms and the response to sulfonylurea treatment in patients with type 2 diabetes: a bioinformatics assessment.
Song J; Yang Y; Mauvais-Jarvis F; Wang YP; Niu T
BMC Med Genet; 2017 Jun; 18(1):64. PubMed ID: 28587604
[TBL] [Abstract][Full Text] [Related]
18. Next generation sequencing targeted gene panel in Greek MODY patients increases diagnostic accuracy.
Tatsi EB; Kanaka-Gantenbein C; Scorilas A; Chrousos GP; Sertedaki A
Pediatr Diabetes; 2020 Feb; 21(1):28-39. PubMed ID: 31604004
[TBL] [Abstract][Full Text] [Related]
19. Congenital Hyperinsulinism and Evolution to Sulfonylurearesponsive Diabetes Later in Life due to a Novel Homozygous p.L171F
Işık E; Demirbilek H; Houghton JA; Ellard S; Flanagan SE; Hussain K
J Clin Res Pediatr Endocrinol; 2019 Feb; 11(1):82-87. PubMed ID: 29739729
[TBL] [Abstract][Full Text] [Related]
20. Genetic and Clinical Characterization of Patients with Maturity-Onset of Diabetes of the Young (MODY): Identification of Novel Variations.
Ateş EA; Üstay Ö; Polat H; Apaydın T; Elbasan O; Yıldırım Ö; Güney Aİ
Balkan Med J; 2021 Sep; 38(5):272-277. PubMed ID: 34462253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
